Correspondence and Reply
Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”

https://doi.org/10.1016/j.jaip.2021.03.031Get rights and content

Cited by (0)

C. L. Haga has received funding from the Schacknow Family Foundation, Inc and previously served as a consultant for the purification of adenovirus-based therapeutics including vaccines for various companies. The rest of the authors declare that they have no relevant conflicts of interest.

View Abstract
© 2021 American Academy of Allergy, Asthma & Immunology